Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aponte

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
Plos Clinical Trials|July 28, 2006
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infectionSonia Enosse, Carlota Dobaño, Diana Quelhas, et al.
The Journal of Infectious Diseases|October 24, 2009
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in GabonMartin P Grobusch, Julian J Gabor, John J Aponte, et al.
Plos One|April 10, 2008
A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinicClara Menéndez, Azucena Bardají, Betuel Sigauque, et al.
Malaria Journal|May 11, 2018
IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancyAlfredo Mayor, Carlota Dobaño, Augusto Nhabomba, et al.
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Malaria Journal|May 11, 2018
High production of pro-inflammatory cytokines by maternal blood mononuclear cells is associated with reduced maternal malaria but increased cord blood infectionCarlota Dobaño, Tamara Berthoud, Maria Nelia Manaca, et al.
The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.
Lancet (London, England)|October 6, 1997
Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infantsC Menendez, E Kahigwa, R Hirt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2018
A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical MalariaCarlota Dobaño, Augusto J Nhabomba, Maria N Manaca, et al.
Tropical Medicine & International Health : TM & IH|January 9, 2007
Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in MozambiqueE Macete, J J Aponte, C Guinovart, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Plos Clinical Trials|July 28, 2006
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infectionSonia Enosse, Carlota Dobaño, Diana Quelhas, et al.
The Journal of Infectious Diseases|October 24, 2009
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in GabonMartin P Grobusch, Julian J Gabor, John J Aponte, et al.
Plos One|April 10, 2008
A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinicClara Menéndez, Azucena Bardají, Betuel Sigauque, et al.
Malaria Journal|May 11, 2018
IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancyAlfredo Mayor, Carlota Dobaño, Augusto Nhabomba, et al.
The Lancet. Infectious Diseases|March 22, 2025
Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trialTsiri Agbenyega, Anne E Schuind, Samuel Adjei, et al.
Malaria Journal|May 11, 2018
High production of pro-inflammatory cytokines by maternal blood mononuclear cells is associated with reduced maternal malaria but increased cord blood infectionCarlota Dobaño, Tamara Berthoud, Maria Nelia Manaca, et al.
The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.
Lancet (London, England)|October 6, 1997
Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infantsC Menendez, E Kahigwa, R Hirt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2018
A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical MalariaCarlota Dobaño, Augusto J Nhabomba, Maria N Manaca, et al.
Tropical Medicine & International Health : TM & IH|January 9, 2007
Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in MozambiqueE Macete, J J Aponte, C Guinovart, et al.
Pageof 19